Praxair, Inc. (PX) Reports In-Line Q2 EPS; Trims FY12 Expectations; Guides Q3 EPS
Tweet
Share
E-mailGet Alerts PX Hot Sheet
Price: $10.54 --0%
Financial Fact:
Income Before Equity Investments: 334M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Income Before Equity Investments: 334M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Praxair, Inc. (NYSE: PX) reported Q2 EPS of $1.42, in-line with the analyst estimate of $1.42. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.93 billion.
Praxair, Inc. sees FY2012 EPS of $5.60-$5.70, versus prior guidance of $5.75-$5.90 and the consensus of $5.79. Praxair, Inc. sees FY2012 revenue of $11.2-$11.5 million, versus prior guidance of $11.6-$11.9 million and the consensus of $11.73 million.
Praxair, Inc. sees Q3 2012 EPS of $1.35-$1.40, versus the consensus of $1.49.
For earnings history and earnings-related data on Praxair, Inc. (PX) click here.
Praxair, Inc. sees FY2012 EPS of $5.60-$5.70, versus prior guidance of $5.75-$5.90 and the consensus of $5.79. Praxair, Inc. sees FY2012 revenue of $11.2-$11.5 million, versus prior guidance of $11.6-$11.9 million and the consensus of $11.73 million.
Praxair, Inc. sees Q3 2012 EPS of $1.35-$1.40, versus the consensus of $1.49.
For earnings history and earnings-related data on Praxair, Inc. (PX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Pfizer reaffirms 2026 guidance after CFO transition news
- JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
